Morningstar Investment Services’s Novartis NVS Stock Holding History

Morningstar Investment Services’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.34M	Sell	20,997 -18,739	-47%	-$1.99M	0.43%	60
2024 Q4	$3.87M	Sell	39,736 -336,180	-89%	-$35.8M	0.35%	70
2024 Q3	$43.5M	Buy	375,916 +918	+0.2%	+$104K	0.44%	64
2024 Q2	$40M	Buy	374,998 +4,004	+1%	+$402K	0.43%	64
2024 Q1	$35.6M	Sell	370,994 -375,842	-50%	-$38.5M	0.39%	70
2023 Q4	$74.7M	Buy	746,836 +371,590	+99%	+$35.9M	0.42%	66
2023 Q3	$38.4M	Sell	375,246 -6,209	-2%	-$630K	0.49%	53
2023 Q2	$37.8M	Sell	381,455 -11,658	-3%	-$1.17M	0.49%	61
2023 Q1	$35.9M	Sell	393,113 -12,282	-3%	-$1.07M	0.48%	65
2022 Q4	$37.2M	Sell	405,395 -14,350	-3%	-$1.21M	0.51%	63
2022 Q3	$33.4M	Sell	419,745 -7,164	-2%	-$594K	0.47%	64
2022 Q2	$36.1M	Sell	426,909 -2,178	-0.5%	-$191K	0.48%	58
2022 Q1	$37.7M	Buy	429,087 +870	+0.2%	+$75.3K	0.42%	64
2021 Q4	$37.4M	Sell	428,217 -6,419	-1%	-$533K	0.42%	61
2021 Q3	$36M	Sell	434,636 -4,325	-1%	-$389K	0.42%	59
2021 Q2	$40.3M	Sell	438,961 -1,562	-0.4%	-$139K	0.48%	54
2021 Q1	$38.3M	Sell	440,523 -29,131	-6%	-$2.61M	0.5%	56
2020 Q4	$44.3M	Sell	469,654 -19,558	-4%	-$1.71M	0.62%	43
2020 Q3	$42.6M	Sell	489,212 -11,728	-2%	-$1.02M	0.66%	41
2020 Q2	$43.7M	Sell	500,940 -20,380	-4%	-$1.76M	0.72%	39
2020 Q1	$42.7M	Buy	521,320 +123,924	+31%	+$11.1M	0.78%	32
2019 Q4	$37.6M	Sell	397,396 -5,232	-1%	-$469K	0.59%	49
2019 Q3	$35M	Sell	402,628 -12,560	-3%	-$1.13M	0.59%	51
2019 Q2	$37.9M	Sell	415,188 -59,871	-13%	-$5.07M	0.62%	46
2019 Q1	$40.9M	Sell	475,059 -17,770	-4%	-$1.43M	0.7%	40
2018 Q4	$37.9M	Sell	492,829 -25,729	-5%	-$2M	0.74%	43
2018 Q3	$40M	Sell	518,558 -21,769	-4%	-$1.61M	0.72%	44
2018 Q2	$36.6M	Buy	540,327 +3,860	+0.7%	+$266K	0.69%	50
2018 Q1	$38.9M	Buy	536,467 +43,309	+9%	+$3.3M	0.76%	47
2017 Q4	$37.1M	Buy	493,158 +26,371	+6%	+$1.99M	0.75%	50
2017 Q3	$35.9M	Buy	466,787 +32,679	+8%	+$2.47M	0.78%	51
2017 Q2	$32.5M	Buy	434,108 +48,187	+12%	+$3.42M	0.75%	49
2017 Q1	$25.7M	Buy	385,921 +59,944	+18%	+$3.99M	0.65%	62
2016 Q4	$21.3M	Buy	325,977 +12,082	+4%	+$784K	0.7%	53
2016 Q3	$22.2M	Buy	313,895 +20,526	+7%	+$1.5M	0.64%	53
2016 Q2	$21.7M	Buy	293,369 +36,633	+14%	+$2.53M	0.69%	47
2016 Q1	$16.7M	Buy	256,736 +85,427	+50%	+$5.81M	0.57%	58
2015 Q4	$13.2M	Buy	171,309 +24,477	+17%	+$1.94M	0.52%	60
2015 Q3	$12.1M	Buy	146,832 +12,678	+9%	+$1.13M	0.51%	61
2015 Q2	$11.8M	Buy	134,154 +19,158	+17%	+$1.76M	0.5%	67
2015 Q1	$10.2M	Buy	114,996 +19,869	+21%	+$1.76M	0.44%	70
2014 Q4	$7.9M	Buy	95,127 +13,236	+16%	+$1.1M	0.37%	76
2014 Q3	$6.91M	Buy	81,891 +5,647	+7%	+$457K	0.36%	75
2014 Q2	$6.18M	Buy	76,244 +7,472	+11%	+$588K	0.36%	75
2014 Q1	$5.24M	Sell	68,772 -42,761	-38%	-$3.12M	0.36%	71
2013 Q4	$8.03M	Buy	111,533 +5,082	+5%	+$353K	0.6%	47
2013 Q3	$7.25M	Buy	106,451 +10,511	+11%	+$695K	0.63%	47
2013 Q2	$6.08M	Buy	+95,940	New	+$6.24M	0.63%	47

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morningstar Investment Services's NVS Position: Q1 2025 in Review

Morningstar Investment Services reduced its Novartis (NVS) stake by 47% in Q1 2025, selling an estimated $1.99M and leaving 20,997 shares worth $2.34M. The position accounts for 0.43% of the portfolio, ranked #60.

Morningstar Investment Services first reported a position in NVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $74.7M in Q4 2023. 1,357 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

Morningstar Investment Services held 20,997 shares of Novartis worth $2.34M as of Q1 2025.
Morningstar Investment Services sold 18,739 Novartis shares in Q1 2025, an estimated $1.99M.
Novartis made up 0.43% of Morningstar Investment Services's portfolio in Q1 2025, its #60 holding.
Morningstar Investment Services first reported a position in Novartis in Q2 2013 and has held it in 48 quarters since.
Morningstar Investment Services's Novartis position peaked at $74.7M in Q4 2023.
1,357 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Morningstar Investment Services's 13F filing for Q1 2025, filed 5 May 2025.